Bellicum Pharmaceuticals, Inc.
Bellicum Pharmaceuticals, Inc. (BLCM) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · BLCM · as of Jun 9, 2026
Key Statistics
Explore Bellicum Pharmaceuticals, Inc. Data
blcm stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 9 · Buy rate: 88.9%
Competitors & Peers
blcm competitorsBLCM
ACOR
BIOL
IMPL
INFIQ
NMTRQStock Performance
Full HistoryAbout Bellicum Pharmaceuticals, Inc.
Bellicum Pharmaceuticals, Inc. (BLCM) operates as a clinical-stage biopharmaceutical firm dedicated to pioneering and advancing innovative cellular immunotherapies. Its primary objective is to combat …
what is bellicum pharmaceuticals, inc. · blcm stock overview · bellicum pharmaceuticals, inc. company profile · who is bellicum pharmaceuticals, inc. ceo · blcm NASDAQ · bellicum pharmaceuticals, inc. headquarters · bellicum pharmaceuticals, inc. business segments
About Stock Overview & Key Data
Bellicum Pharmaceuticals, Inc. (BLCM) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Dec 18, 2014. As of the latest trading session, BLCM stock price is $0.07, with a market capitalization of $778,326. The stock has returned -76.64% over the past 12 months and -50.82% year-to-date.
According to 9 Wall Street analysts, the consensus rating for Bellicum Pharmaceuticals, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2022, Bellicum Pharmaceuticals, Inc. reported revenue of $1.5M and net income of -$25.0M. For detailed data — including Bellicum Pharmaceuticals, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Bellicum Pharmaceuticals, Inc. (BLCM) stock price is $0.07. The stock is traded on NASDAQ under the ticker symbol BLCM. The 52-week range is $0.06 – $1.31.